Hannah Freeman Honored with Euromoney’s Rising Stars Awards: Americas

Practices: Intellectual Property, Intellectual Property Transactions, IP Structuring in M&A, Spinouts & Reorganizations, Strategic Licensing Programs, Joint Ventures, Collaborations and Alliances, IP-Backed Finance, Strategic Commercial Agreements, Health Care

At a virtual ceremony on January 28, life sciences licensing and collaboration partner Hannah Freeman (Boston) was honored with Euromoney’s “Rising Stars Awards: Americas” in the “Life Sciences” and “United States” categories. The awards were highlighted in Managing Intellectual Property. 

Among other achievements, Hannah was recognized for advising Sarepta Therapeutics licensing agreement with Roche valued at $1.15 billion for Sarepta’s single treatment gene therapy for Duchenne muscular dystrophy. 

Euromoney Rising Stars Awards editorial staff selects legal professional rising stars under age 40 based on their professional accomplishments, advocacy and influence within their specialty of the preceding year, as well as peer review.

Hannah was previously honored with an LMG Life Sciences Award for Financial & Corporate Rising Star and Impact Deal of the Year for advising Sarepta Therapeutics licensing agreement with Roche.

Cookie Settings